UnknownPhase 3

Effect of a Hydrogen-Peroxide and Hyaluronic-Acid Mouthwash (BMG0703) in the Treatment of Periodontitis

Italy50 participantsStarted 2020-06

Plain-language summary

Assessment of the efficacy of BMG0703 in the treatment of periodontitis and control of supragingival plaque, compared to Chlorhexidine and a placebo product

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Presence of periodontitis with pockets between 3 and 7 mm * Acceptance of informed consent Exclusion Criteria: * subjects suffering from HIV * subjects suffering from hepatitis * serious systemic diseases preventing the use of specific dental therapies * acute and/or chronic infectious pathologies * inability to provide consent * use of topical or systemic drugs * inability to follow post-intervention hygiene instructions * smokers

What they're measuring

Change in Bleeding index

Timeframe: 0, 3, 7, 30 days

Change in Plaque index

Timeframe: 0, 3, 7, 30 days

Trial details

NCT IDNCT04446533

SponsorUniversity of Milan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-07

Contact for this trial

Chiara Occhipinti, Professor

+393339155689 Chiara.Occhipinti@unimi.it

View on ClinicalTrials.gov More Periodontitis trials